CHRISTINA REDMOND: Open Payments
NPI 1437183373 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 20 payments from 7 companies in 2025. Trend: 2023 $384 · 2024 $475 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 2 | $182 |
| AstraZeneca Pharmaceuticals LP | 6 | $173 |
| PFIZER INC. | 6 | $142 |
| ABIOMED | 2 | $52 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $36 |
| Amgen Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: Attruby, ELIQUIS, WAINUA, FARXIGA, VYNDAQEL, LifeVest, REPATHA, VERQUVO.
Industry payments across WA — which companies pay providers there.
